Immunome Inc (IMNM) - News Archive

In this diligent age of scientific advancement, the realm of biotechnology finds itself afire with illuminating discoveries that promise to transform the landscape of oncological care. The latest missive from the esteem...

: Immunome, Inc., a promising player in the biotechnology sector, has demonstrated resilience and innovation in its recent financial results for the second quarter of 2024. This article provides an overview of the compa...

In recent developments that demonstrate its commitment to advancing targeted cancer therapies, Immunome, Inc. (Nasdaq: IMNM), a renowned biotechnology firm based in Bothell, Washington, announced strategic moves that ar...

BOTHELL, Wash. Immunome, Inc. (Nasdaq: IMNM), a biotech firm renowned for its pioneering work in developing targeted cancer therapies, has announced the successful acquisition of antibodies and related assets from Atrec...

In the pursuit of groundbreaking targeted cancer therapies, biotechnology company Immunome Inc. has chosen Arrayjet s ArrayPlex discovery platform to bolster its in-house high-throughput screening tools. Through this co...